fer aggressive life-sustaining treatment than whites (4 -7) . Yet the majority of black elders, like white elders, do not prefer such treatment (8) .
Like other statistical phenomena, the higher relative rate among blacks for end-of-life ICU and life-sustaining treatment use, compared to whites, could lead physicians to assume larger differences in base rates than actually exist. This may lead to cognitive biases in decisionmaking, particularly under conditions of time pressure and uncertainty (9 -14) . We hypothesized that some of the observed racial differences in end-of-life ICU and life-sustaining treatment use could be attributable to cognitive biases that lead to different treatment decisions by race among hospital-based physicians.
The purpose of this exploratory study was to test whether hospital-based physicians made different ICU and life-sustaining treatment decisions for otherwise identical black and white patients with end-stage cancer and life-threatening hypoxia and whether differences, if they exist, were attributable to race-based beliefs about treatment preferences.
MATERIALS AND METHODS
We conducted a randomized factorial trial of the relationship between patient race and physician treatment decisions using highfidelity simulation. We counterbalanced the effects of race and case by randomly alternating their order using a table of random permutations. The simulation has been validated to mimic the time-pressured decisions regarding ICU admission and intubation faced by hospital-based physicians for an acutely unstable terminally ill patient (15) . We reduced race to the phenotypic expression of a patient's heritage (e.g., predominantly skin color); the patient simulators did not differ in preferences, socioeconomic status, or verbal and nonverbal behaviors.
Subject Recruitment
We used a combination of probability sampling and convenience sampling to recruit emergency physicians, hospitalists, and intensivists.
Simulation
Each physician subject participated in one simulated clinical encounter with a black patient and in one with a white patient at the University of Pittsburgh Peter M. Winter Institute for Simulation Education and Research. The encounters were separated by a distracting task lasting 10 mins. Following the approach we developed previously (15) , the clinical encounters took place on a hospital set (emergency department set for emergency physicians, ward set for hospitalists and intensivists) by trained patient simulators playing the patient and his wife or sister. We provided clinical data in an electronic medical recordbased chart and bedside vital signs monitor. A real nurse executed the physician orders at the bedside and an investigator in charge of the simulation answered any unanticipated physician diagnostic or therapeutic requests through an intercom speaker from the observation room.
We trained four black and four white actors to use a combination of scripted answers to anticipated questions and response principles (see Supplemental Digital Content 1, http://links.lww.com/CCM/A254). We designed the response principles such that the physicians, not the actors, would lead discussions about decision-making and practiced using 12 hrs of role playing, including formal dress rehearsal with three volunteer physicians. We used multiple actors in equal frequencies to minimize potential for an actor effect (Figs. 1 and 2).
The two cases that we randomly alternated with race differed in noninformative social details and were considered clinically to be prognostically identical (Appendix 1). The clinical conditions had parallel differential diagnoses: likely progression of cancer with a (potentially reversible) infectious process as a possible coincident or alternate cause. Mr. Jenkins, accompanied by his caregiver/surrogate wife, was a 78-yr-old retired Catholic English teacher with metastatic gastric cancer admitted from skilled nursing for shortness of breath; a spiral computed tomography ruled out pulmonary embolism and suggested lymphangitic spread of the tumor as the most likely cause of the shortness of breath, although the admitting team had begun empirical antibiotic therapy for pneumonia. His daughter lives in Hawaii with her family, and she was last home during her father's recent complicated admission for gastrectomy. Mr. Thomas, accompanied by his caregiver/ surrogate sister, was a 76-yr-old retired Protestant bank manager with metastatic pancreatic cancer admitted from skilled nursing for abdominal pain; an abdominal computed tomography and laboratory values suggested biliary obstruction attributable to liver metastasis as the most likely cause of the abdominal pain, although the admitting team had begun empirical antibiotic therapy for cholangitis. His son is deployed in Iraq and was provided leave for his father's recent complicated admission for pancreaticoduodenectomy. We asked subjects to imagine a nurse had summoned them to the bedside, approximately 8 -12 hrs after initial presentation, to assess the patient's identical deteriorating vital signs: tachypnea, tachycardia, hypotension, and hypoxia.
In both cases, the chart contained no prognostic or treatment information from the oncologist or an advance care plan. If probed during the course of the simulation, then the patient and his caregiver would reveal they know the tumor to be widely metastatic, that the treating oncologist said he was too weak to receive chemotherapy and he might die within 6 months, and that they prefer not to be admitted to the ICU or to receive mechanical ventilation or cardiopulmonary resuscitation.
Data Collection
Two physician investigators (A.B. and D.M.) independently performed one of each subjects' two simulation encounters. We recorded treatment decisions made during the simulation encounter on a standardized form. After each encounter, the physician subject wrote a brief chart note and orders using a web-based survey in an adjacent conference room. We used data from treatment decisions observed during the encounter and recorded in the chart note and orders to create nine nonmutually exclusive individual treatment decisions (provision of opiates for symptom palliation during the simulation encounter; a trial of noninvasive mechanical ventilation during the simulation; elicitation of intubation preferences; documentation of a do not intubate order in the chart; admission to the ICU; respiratory intubation and mechanical ventilation; initiation of comfort measures only; palliative intent; and palliative care consultation).
We also collected physician subject demographic, training, and employment information, and the diagnosis, prognosis, and perceptions of the treatment goals for each case.
After simulation and interview completion, we collected subjects' beliefs about treatment preferences among black and white patients with metastatic pancreatic cancer. Finally, we asked subjects whether they had read the investigators' previously published pilot feasibility study and invited them to venture a guess regarding the hypothesis undergoing testing.
Analyses
We descriptively summarized the characteristics of the physician subjects and their prognostic assessments of the two cases. We assessed the bivariate relationship between predictors (case, race) and each of the nine dichotomous decisions using McNemar's test for within-subject comparison (matched black vs. white patient pairs in which each physician served as their own control) and the Fisher's exact test for between-subject comparison (limiting the black vs. white patient comparison to each physician's first encounter to eliminate contamination effects). We used logistic regression with subject-level random effects to assess the multivariable relationship between case, race, and order and treatment decisions for the within-subject comparisons, and logistic regression to assess the multivariable relationship between case and race and treatment decisions for the between-subject analyses. We used the Wilcoxon signed rank test to compare physicians' beliefs about preference, by race, for chemotherapy, mechanical ventilation, and a do-not-resuscitate order. This was an exploratory study without an a priori estimate of effect size (Discussion shows post hoc power calculation). Any associations at p Յ .1 were considered suggestive of a positive association. We used Stata 10.0 (College Station, TX) for all analyses.
Human Subjects
The protocol was approved by the University of Pittsburgh Institutional Review Board, which required deliberate omission of the specific study purpose from the consent form (race-based differences in end-of-life decisionmaking and communication). Subjects completed written informed consent with the understanding that they were participating in a study of treatment decisions for critically ill patients made by hospital-based providers who do not have an established relationship with the patient. Subjects received $200 for their 2-hr participation.
RESULTS

Subjects
We recruited 15 subjects through medical society and hospital lists and 18 through professional contacts (see Supplemental Digital Content 2, http://links.lww.com/CCM/A255). We report the characteristics of the 33 physician subjects in Table 1 . None of the study subjects read the manuscript describing our pilot work before participation. Three (9%) guessed that the hypothesis we were testing was about patient race.
We removed one subject's treatment decision data for both of his encounters because of errors in actor responses that may have biased the doctor's treat- 
Simulation Treatment Decisions
In crude and adjusted within-subject and between-subject comparisons of treatment decisions for the black vs. white patients, there were no differences in provision of an opiate during the simulation, a trial of noninvasive mechanical ventilation, elicitation of intubation preferences, chart documentation of preferences, ICU admission, intubation, comfort measures only, palliative intent, and palliative care consultation ( Table 2) .
In crude and adjusted within-subject and between-subject comparisons of treatment decisions for the gastric cancer vs. pancreatic cancer case, physicians were more likely to provide an opiate for the pancreatic cancer patient with pain and more likely to attempt a trial of noninvasive mechanical ventilation for the gastric cancer with dyspnea (Table 3 ). In the between-subject comparisons only, physicians were more likely to admit the pancreatic cancer patient to the ICU and less likely to treat with palliative intent (Table 3 ).
Beliefs About Preferences By Race
Based on survey self-report, physician subjects believed that a black patient with metastatic pancreatic cancer was more likely than a similar white patient to prefer potentially life-prolonging chemotherapy over treatment focused on palliation (67% vs. 64%; z ϭ Ϫ1.79; p ϭ .07) and to want mechanical ventilation for 1 wk of life extension (43% vs. 34%; z ϭ Ϫ2.93; p ϭ .003), and less likely to want a do-not-resuscitate order if hospitalized (51% vs. 60%; z ϭ 3.03; p ϭ .003).
Perceptions About Case
A similar proportion of physician subjects attributed the pancreatic cancer patient's deterioration to infection (16; 50%) versus to cancer (15; 47%); but for the gastric cancer patient, more than 21 (66%) attributed the deterioration to the cancer compared to seven (22%) who attributed it to infection. Nonetheless, prognostic estimates for the pancreatic and gastric cancer cases were similar: 21 (66%) and 25 (78%) predicted Ͻ10% 3-month survival rate and 12 (38%) and 13 (41%) predicted Ͻ 10% survival to discharge with no treatment limitation.
DISCUSSION
In this exploratory, randomized, factorial simulation trial, we demonstrated significant variation in the use of the ICU, life-sustaining treatment, and palliative care for a critically ill elder patient with end-stage cancer. This variation, however, did not appear to be influenced by the race of the patient. This finding was particularly notable given physician subjects' selfreported beliefs that black patients with metastatic cancer prefer more life-prolonging treatment than white patients. This is the first study to our knowledge to use high-fidelity simulation to explore the relationship between patient race and physicians' end-of-life decisionmaking. Previous studies using video vignettes alone (16) and in conjunction with implicit association tests (17) in the area of cardiovascular disease reveal that physician treatment decisions for otherwise identical black and white patients differ, and that some, but not all, of the difference is explained by physicians' prior beliefs about risk and benefit by race. In another study of physician-reported diagnoses after patient consultation, differences in plausible prior beliefs explained racial differences in diagnosis of hypertension and diabetes (11) . Like the physicians in those studies, our subject physicians held prior race-based beliefs. Their beliefs about blacks' higher likelihood for preferring life-prolonging drugs and mechanical ventilation and lower likelihood for preferring a do-not-resuscitate order corresponded with reports in the literature, although they overestimated by severalfold the absolute probabilities of preferences for intensive treatments for both races (8, 18 -20) . We did not have the occasion to explore whether these prior beliefs mediated race-based differences in treatment because we did not find treatment differences.
There are several plausible explanations for lack of race-based differences in physician treatment decisions. First, the physician's prior beliefs may not distort their decision-making. This could be be- cause, unlike the diagnostic and treatment decisions explored in these prior studies, in which the "true" state may not be directly observed without further (delayed) diagnostic testing, the preferences for life-sustaining treatment in our simulation could be "tested" right away by asking the patient a question. Although in eight encounters the subject physician failed to ask about intubation preferences (and so intubated the patient), most physicians did ask, and there was no difference in the elicitation of intubation preferences by patient race.
Second, our findings might not reflect "real-world" race-based differences in physician decision-making because we oversimplified the construct of race. That is, by isolating race to appearance and standardizing away social and cultural variables that sometimes confound race, such as socioeconomic status, religiosity, trust, and level of advance care planning, we may have stripped away the real stimuli that moderate race-based differences in physician behavior. For example, it is possible that physicians respond differently to black and white mistrust, and that this complexity might give rise to treatment differences by race. Yet we argue that ours is the necessary first step in deconstructing this complex social question as others have sought to do by teasing confounders in observational samples (21, 22) . Given the feasibility of simulation demonstrated by the current study, our future studies could experimentally manipulate sociocultural confounders to explore their impact on physician decision-making.
Third, and perhaps most importantly, our study was underpowered. There were no prospective estimates of expected rates of ICU admission and intubation among black and white elder patients with endstage cancer and acute respiratory failure to use as effect size estimates, let alone estimates of provider-attributable differences. Assuming a 10% provider-attributable difference to be "clinically important," the information on concordance from our sample of 32 evaluable subjects suggests that 124 and 301 providers, respectively, would have been required to find a clinically important difference in intubation and ICU admission using a within-subjects design. Nonetheless, we can place the low power for a race finding in the context of the unexpected finding that the particular type of cancer (gastric vs. pancreatic) and presenting symptoms of infiltration (lung vs. liver)-what we believed were noninformative aspects of the case-affected physician decisionmaking. Specifically, if there are racebased differences in decision-making, they must be smaller than those caused by case for them not to have been identified in the current study. The cause of the differences in decision-making by case is unknown. We conjecture that the pancreatic cancer patient's chief symptom of pain prompted more opiate use during the simulation (even though opiates are also effective for dyspnea) and that the gastric cancer patient's chief symptom of dyspnea prompted more use of noninvasive mechanical ventilation (even though the pancreatic cancer patient's respiratory status was identical).
We also conjecture that the physicians were more likely to admit the pancreatic cancer patient to the ICU and less likely to treat with palliative intent because they more commonly perceived that the proximate cause of the pancreatic cancer patient's compromise was infection (rather than cancer). This may have influenced their perception of the proximate condition's "reversibility," even though the physicians' hospital and 3-month prognostic estimates for the two cases were identical.
Our study has several strengths. By using simulation, we were able to study a decision context (ICU triage) that is difficult to study in the real world because it is unscheduled and time-pressured. Simulation also allowed us to experimentally manipulate the independent variablerace. Despite the artificial setting and experimental manipulations, physicians suspended disbelief and seldom guessed that the study was about race. Nevertheless, we cannot rule out a Hawthorne effect. It is possible that physicians' behavior in the simulation may not reflect their actual practice (23) . By being on their "best behavior" during observation, they may have suppressed any race-based differences in behavior even if they did not know that the study was about race. Yet we studied a heterogeneous group of physicians from major and minor teaching hospitals. Also, we explored our findings using two analytic designs: within-subject and between-subject comparisons. Within-subject comparisons, by allowing each subject to serve as his or her own control, make it easier to attribute differences in responses to the experimental condition, rather than to potentially confounding individual subject characteristics; however, they are subject to carryover effects such as fatigue (increasing error variance), anchoring (bias toward the null), contrast effects (bias toward finding difference), and demand effects (decreasing validity). Between-subject comparisons avoid carryover effects but may require unfeasibly large sample sizes. Although ours was an exploratory study without prespecified effect sizes, neither analytic strategy suggested an independent effect of race, and we did find evidence of potential crosscase contamination, including a carryover effect.
There are other threats to generalizability beyond our isolation of the effect of race based on appearance alone. First, we designed the clinical scenario to be relatively simple. We removed the diagnostic challenge with a patient who has undergone a full work-up. We limited the decision makers to two parties-the patient and his surrogate-who both understood the underlying cancer prognosis and had previously discussed life-sustaining treatment preferences. Such conditions may be uncommon. If the diagnosis were more opaque, if there were more decision-makers involved, less insight into prognosis, or more ambivalence about treatment preferences, we likely would have observed more intensive treatment and perhaps greater variation. Second, we recruited subject physicians from one region and only two of them were black. Although the proportion of Pittsburgh's patient population that is black is similar to the nation overall (13%), the existence of race-based differences in physician end-of-life decisionmaking may vary across regions.
In conclusion, in this pilot study, we found that patient race alone did not influence treatment decisions by hospitalbased physicians in response to lifethreatening hypoxia in an elderly patient with end-stage cancer and stable preferences to avoid intensive care. Future work should explore the interaction of race, socioeconomic, and cultural variables in endof-life decision-making across varying preference conditions in larger, more regionally diverse physician samples.
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